HKU Gets Green Light For Nasal Covid Vaccine Trials
"); jQuery("#212 h3").html("
"); });
2020-09-09 HKT 19:19
Share this story
The University of Hong Kong says mainland authorities have allowed clinical trials of a nasal spray vaccine for Covid-19 it has been developing with mainland institutions.
The State Key Laboratory of Emerging Infectious Diseases of the university's Department of Microbiology has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.
It says it is the only nasally-administered vaccine against the disease to be allowed for clinical trials so far by the National Medical Products Administration.
China To Inject US$44 Billion Into State Banks To Boost Tech And Curb Risks
China said it will inject 300 billion yuan (US$44 billion) into state-owned banks this year to guard against systemic r... Read more
Hong Kong Regulators Expand GenAI Sandbox To Insurance, Securities And MPF Sectors
The Hong Kong Monetary Authority (HKMA), Securities and Futures Commission (SFC), Insurance Authority (IA), and Mandato... Read more
South Korea To Cap Crypto Exchange Ownership At 20%
South Korean regulators and lawmakers have agreed to cap major shareholder stakes in cryptocurrency exchanges at 20%, d... Read more
DBS Hong Kong Partners With Know Your Customer To Automate SME Onboarding
Know Your Customer Limited, a provider of automated business verification solutions, has partnered with DBS Hong Kong t... Read more
Hong Kong Banks Extend Loan Repayment Relief For Tai Po Fire Victims
The Hong Kong Monetary Authority (HKMA) and the Hong Kong Association of Banks (HKAB) have met to discuss additional su... Read more
Hong Kong And Macao Deepen Financial Cooperation With Updated Agreement
The Hong Kong Monetary Authority (HKMA) and the Monetary Authority of Macao (AMCM) held a meeting on March 3 to strengt... Read more